KATELYN STENGER: Open Payments
NPI 1417201617 · UNIONTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 16 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $426 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 1 | $113 |
| Lundbeck LLC | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Alkermes, Inc. | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: ABILIFY MAINTENA, SUBLOCADE, UZEDY, LYBALVI, ARISTADA, CAPLYTA, TRINTELLIX, INGREZZA.
Industry payments across OH — which companies pay providers there.
